0001637761-23-000042.txt : 20230109
0001637761-23-000042.hdr.sgml : 20230109
20230109191956
ACCESSION NUMBER: 0001637761-23-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230109
DATE AS OF CHANGE: 20230109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FEKETE MICHAEL
CENTRAL INDEX KEY: 0001581383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36905
FILM NUMBER: 23519414
MAIL ADDRESS:
STREET 1: C/O SAGENT PHARMACEUTICALS, INC.
STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700
CITY: SCHAUMBURG
STATE: IL
ZIP: 60195
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SeaSpine Holdings Corp
CENTRAL INDEX KEY: 0001637761
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473251758
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5770 ARMADA DRIVE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 727-8399
MAIL ADDRESS:
STREET 1: 5770 ARMADA DRIVE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
wf-form4_167330998234225.xml
FORM 4
X0306
4
2023-01-05
1
0001637761
SeaSpine Holdings Corp
SPNE
0001581383
FEKETE MICHAEL
C/O SEASPINE HOLDINGS CORPORATION
5770 ARMADA DRIVE
CARLSBAD
CA
92008
1
0
0
0
Common Stock
2023-01-05
4
D
0
111966
D
0
D
Stock Option (right to buy)
15.68
2023-01-05
4
D
0
59910
D
2025-08-01
Common Stock
59910.0
0
D
Stock Option (right to buy)
17.18
2023-01-05
4
D
0
5015
D
2026-01-01
Common Stock
5015.0
0
D
Stock Option (right to buy)
9.99
2023-01-05
4
D
0
18096
D
2026-06-07
Common Stock
18096.0
0
D
Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 46,611 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,940 shares of Orthofix at a price of $37.67 per share.
The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,087 shares of Orthofix at a price of $41.27 per share.
The option vests in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,533 shares of Orthofix at a price of $24.00 per share.
/s/ Paul Benny, Attorney-in-Fact for Michael Fekete
2023-01-09